HOLOGIC INC — Director's Dealing 2013

Feb 28, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HOLOGIC INC (HOLX)
CIK: 0000859737
Period of Report: 2013-02-27

Reporting Person: SOLTANI PETER (SVP & GM, Women's Health)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-27	Common Stock	M	32000	$14.50	Acquired	88704	Direct
2013-02-27	Common Stock	S	32000	$22.05	Disposed	56704	Direct
2013-02-27	Common Stock	M	12000	$13.63	Acquired	68704	Direct
2013-02-27	Common Stock	S	12000	$22.02	Disposed	56704	Direct
2013-02-27	Common Stock	M	24729	$15.75	Acquired	81433	Direct
2013-02-27	Common Stock	S	24729	$22.05	Disposed	56704	Direct
2013-02-27	Common Stock	M	20000	$13.865	Acquired	76704	Direct
2013-02-27	Common Stock	S	20000	$22.05	Disposed	56704	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-27	Non-qualified Stock Option (Right to Buy)	$14.50	M	32000	Disposed	2015-11-13	Common Stock (32000)	Direct
2013-02-27	Non-qualified Stock Option (Right to Buy)	$13.63	M	12000	Disposed	2016-06-22	Common Stock (12000)	Direct
2013-02-27	Non-qualified Stock Option (Right to Buy)	$15.75	M	24729	Disposed	2016-11-11	Common Stock (24729)	Direct
2013-02-27	Non-qualified Stock Option (Right to Buy)	$13.865	M	20000	Disposed	2015-10-31	Common Stock (20000)	Direct

Footnotes

F1: The transaction reported herein reflects an aggregate of sales at prices ranging from $22.01 to $22.085, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares sold at each separate price.

F2: The transaction reported herein reflects an aggregate of sales at prices ranging from $22.01 to $22.06, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares sold at each separate price.

F3: The transaction reported herein reflects an aggregate of sales at prices ranging from $21.99 to $22.16, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares sold at each separate price.

F4: The transaction reported herein reflects an aggregate of sales at prices ranging from $21.99 to $22.152, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full disclosure with respect to the number of shares sold at each separate price.

F5: The option becomes exercisable in five equal annual installments beginning November 13, 2009

F6: The option becomes exercisable in five equal annual installments beginning June 22, 2010.

F7: The option, issued pursuant to the 2008 Equity Incentive Plan, becomes exercisable in five equal annual installments beginning November 11, 2010.